Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
533.2 INR | +0.10% | -2.63% | +47.64% |
Sales 2024 * | 14.31B 172M | Sales 2025 * | 17.07B 205M | Capitalization | 19.19B 230M |
---|---|---|---|---|---|
Net income 2024 * | -3.21B -38.49M | Net income 2025 * | 293M 3.51M | EV / Sales 2024 * | 1.34 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.12 x |
P/E ratio 2024 * |
-
| P/E ratio 2025 * |
65.4
x | Employees | 2,361 |
Yield 2024 * |
-
| Yield 2025 * |
0.56% | Free-Float | 43% |
Latest transcript on Solara Active Pharma Sciences Limited
1 day | +0.10% | ||
1 week | -2.63% | ||
Current month | +43.74% | ||
1 month | +35.16% | ||
3 months | +37.62% | ||
6 months | +72.25% | ||
Current year | +47.64% |
Managers | Title | Age | Since |
---|---|---|---|
Poorvank Purohit
CEO | Chief Executive Officer | - | 23-02-02 |
Sudhir Nambiar
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Operating Officer | 52 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Arun N. Kumar
BRD | Director/Board Member | 63 | - |
Chief Operating Officer | 52 | 18-12-31 | |
Director/Board Member | 40 | 19-05-15 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 117 M€ | +1.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 533.2 | +0.10% | 178,512 |
24-04-30 | 532.6 | +0.95% | 192,385 |
24-04-29 | 527.6 | -2.71% | 169,922 |
24-04-26 | 542.4 | -3.29% | 200,663 |
24-04-25 | 560.8 | +1.67% | 287,023 |
Delayed Quote NSE India S.E., May 02, 2024 at 07:43 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+47.64% | 230M | |
+29.68% | 699B | |
+25.07% | 571B | |
-4.35% | 364B | |
+17.65% | 326B | |
+3.77% | 286B | |
+14.68% | 236B | |
+4.71% | 198B | |
-12.43% | 194B | |
-3.79% | 154B |
- Stock Market
- Equities
- SOLARA Stock